Key result
Total laryngectomy followed by chemo-radiotherapy for laryngeal synovial sarcoma resulted in no macroscopic signs of tumoral relapse over 2 years of follow-up.
Why the study?
Laryngeal synovial sarcoma is an extremely rare mesenchymal tumor, with under 40 cases reported in the literature over the past four decades.
Population
One 70-year-old male patient with a tumor obstructing the laryngeal glottis
Design
Case report
Follow-up
2 years
Authors
Loading...
Supports multimodality therapy in rare laryngeal synovial sarcoma; extends sparse reports but leaves optimal management open.
Case Report (n=1)
Total laryngectomy followed by chemo-radiotherapy resulted in no macroscopic signs of tumoral relapse at 2 years in a rare case of laryngeal synovial sarcoma.
Vlăescu et al. (2020) conducted a case report in Laryngeal synovial sarcoma (n=1). Total laryngectomy followed by chemo-radiotherapy was evaluated on Macroscopic signs of tumoral relapse. Total laryngectomy followed by chemo-radiotherapy for laryngeal synovial sarcoma resulted in no macroscopic signs of tumoral relapse over 2 years of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: